204 related articles for article (PubMed ID: 33496742)
1. Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer.
Hisada Y; Garratt KB; Maqsood A; Grover SP; Kawano T; Cooley BC; Erlich J; Moik F; Flick MJ; Pabinger I; Mackman N; Ay C
Blood Adv; 2021 Jan; 5(2):487-495. PubMed ID: 33496742
[TBL] [Abstract][Full Text] [Related]
2. Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.
Diaz JA; Ballard-Lipka NE; Farris DM; Hawley AE; Wrobleski SK; Myers DD; Henke PK; Lawrence DA; Wakefield TW
J Vasc Surg; 2012 Mar; 55(3):815-22. PubMed ID: 22119245
[TBL] [Abstract][Full Text] [Related]
3. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.
Baldwin JF; Sood V; Elfline MA; Luke CE; Dewyer NA; Diaz JA; Myers DD; Wakefield T; Henke PK
J Vasc Surg; 2012 Oct; 56(4):1089-97. PubMed ID: 22796119
[TBL] [Abstract][Full Text] [Related]
4. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
[TBL] [Abstract][Full Text] [Related]
5. Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis.
Belghasem M; Roth D; Richards S; Napolene MA; Walker J; Yin W; Arinze N; Lyle C; Spencer C; Francis JM; Thompson C; Andry C; Whelan SA; Lee N; Ravid K; Chitalia VC
Blood; 2019 Dec; 134(26):2399-2413. PubMed ID: 31877217
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma.
Chen N; Ren M; Li R; Deng X; Li Y; Yan K; Xiao L; Yang Y; Wang L; Luo M; Fay WP; Wu J
Mol Cancer; 2015 Jul; 14():140. PubMed ID: 26215730
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of uPA, tPA, and PAI-1 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation.
Nosaka M; Ishida Y; Kuninaka Y; Kimura A; Kondo T
Int J Legal Med; 2012 May; 126(3):421-5. PubMed ID: 22361951
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.
Frischmuth T; Hindberg K; Aukrust P; Ueland T; Braekkan SK; Hansen JB; Morelli VM
J Thromb Haemost; 2022 Jul; 20(7):1618-1626. PubMed ID: 35289062
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent thrombus resolution due to oral plaminogen activator inhibitor (PAI)-1 inhibition with tiplaxtinin in a rat stenosis model of venous thrombosis.
Baxi S; Crandall DL; Meier TR; Wrobleski S; Hawley A; Farris D; Elokdah H; Sigler R; Schaub RG; Wakefield T; Myers D
Thromb Haemost; 2008 Apr; 99(4):749-58. PubMed ID: 18392333
[TBL] [Abstract][Full Text] [Related]
12. Serpins in Venous Thrombosis and Venous Thrombus Resolution.
Mukhopadhyay S; Johnson TA; Sarkar R; Antalis TM
Methods Mol Biol; 2018; 1826():197-211. PubMed ID: 30194602
[TBL] [Abstract][Full Text] [Related]
13. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism.
Sood V; Luke CE; Deatrick KB; Baldwin J; Miller EM; Elfline M; Upchurch GR; Wakefield TW; Henke PK
Thromb Haemost; 2010 Dec; 104(6):1174-83. PubMed ID: 20886179
[TBL] [Abstract][Full Text] [Related]
14. Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.
Humphries J; Gossage JA; Modarai B; Burnand KG; Sisson TH; Murdoch C; Smith A
J Vasc Surg; 2009 Nov; 50(5):1127-34. PubMed ID: 19703758
[TBL] [Abstract][Full Text] [Related]
15. Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models.
Hisada Y; Mackman N
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):182-186. PubMed ID: 31808871
[TBL] [Abstract][Full Text] [Related]
16. Aging is associated with impaired thrombus resolution in a mouse model of stasis induced thrombosis.
McDonald AP; Meier TR; Hawley AE; Thibert JN; Farris DM; Wrobleski SK; Henke PK; Wakefield TW; Myers DD
Thromb Res; 2010 Jan; 125(1):72-8. PubMed ID: 19616825
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M
Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171
[No Abstract] [Full Text] [Related]
18. Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells.
Lupu-Meiri M; Geras-Raaka E; Lupu R; Shapira H; Sandbank J; Segal L; Gershengorn MC; Oron Y
J Cell Physiol; 2012 Nov; 227(11):3621-8. PubMed ID: 22331587
[TBL] [Abstract][Full Text] [Related]
19. Venous stasis-induced fibrinolysis prevents thrombosis in mice: role of α2-antiplasmin.
Singh S; Houng AK; Reed GL
Blood; 2019 Sep; 134(12):970-978. PubMed ID: 31395599
[TBL] [Abstract][Full Text] [Related]
20. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
